Perfect Your Patent Prosecution Strategies and Master the Patent Application Process in the U.S and Around the World

ACI’s 18th Global Summit on Life Sciences Patents returns to New York this May to provide practical insights on how to maximize patent life cycles and develop strategies to enhance patent portfolio protections.

By amalgamating the practical experiences and unique insights of leading in-house IP counsel, patent prosecutors and litigators, the USPTO, and policy experts from both sides of the Atlantic, this conference is a must-attend industry event.

Complete agenda, speakers list and more are now available!

Meet the Co-Chairs
Dr. Leslie Fischer

Dr. Leslie Fischer

Principal Patent Attorney, I & D Patent Group
R & D Intellectual Property Unit Site Head, NPC

“The ACI Life Science conference is absolutely my go-to conference every year – one I simply do not miss. The panels are excellent and always on point, with timely topics and engaging speakers. And, although held in NYC, this conference provides global patent insights. We’ve had speakers from all over the world, talking about issues as diverse as Brexit and the Unified Patent Court, sufficiency issues for antibodies in Japan, patent extensions in Canada, and double patenting in the U.S. If you only go to one patent event for life sciences in 2020, this should be it.”

Duane C. Marks

Duane C. Marks

Assistant General Patent Counsel
Eli Lilly and Company

“Every year, ACI’s Life Science Patent conference delivers an agenda chalked full of the most relevant topics discussed by some of the top professionals in our field. And, I’ve always found the Life Science Patent conference affords the best chance to network and catch up with peers throughout the industry. It’s definitely a conference I look forward to year after year!”

Insights from Key Industry Leaders
Heather Boussios

Heather Boussios

Assistant General Counsel – IP
Aptevo Therapeutics

Gloria Fuentes

Gloria Fuentes

Executive Director, Corporate Transactions

Yu Ming Dammann

Yu Ming Dammann

Associate General Counsel
Gilead Sciences

Jeffrey Kopacz

Jeffrey Kopacz

Vice President IP
Omega Therapeutics

Brendan M. O'Malley

Brendan M. O’Malley

Vice President, Chief IP Counsel
Abeona Therapeutics Inc.

Guido Pontremoli

Guido Pontremoli

Corporate IP Patent Director
Chiesi Farmaceutici S.P.A

Join us for In-Depth Discussions and Analysis on
  • Strengthening International Patent Protection for Small Molecules and Antibodies by Enhancing Written Description and Enablement
  • Exploring the Realities of the New USPTO Guidance on Section 101 to Uncover New Meaning of “Invention or Discoveries”
  • Understanding How the Latest Doctrine of Equivalents Decisions in the U.S., Europe and Asia is Influencing Patent Protection Strategies
  • Minimizing Infringement Risks in Licensing Agreements In the U.S. and Europe
  • Social Contracting: How Does This Affect the Design of Patent Portfolios
  • Examining Inherency and Obviousness from Brand and Generic Perspectives in the U.S. and Europe

We look forward to seeing you in New York this May. Attend this event and be part of the leading global Life Sciences community with the goal of protecting innovation in the life sciences sphere. Register Now!

Register Now
This Is a Must Attend Event For

Intellectual Property Practitioners:

  • Patent attorneys
  • Patent agents
  • Patent litigators

Who represent:

  • Pharmaceutical Companies
  • Biotech Companies
  • Diagnostic Companies
  • HealthTech Startups
Here’s what some of our attendees had to say about this one-of-a-kind event
Quote Icon

This event not to be missed!

Quote Icon

Good mix of in-house, private practice, and government

Quote Icon

Very enjoyable – wonderful speakers that are well qualified – great content